Biolase, Inc. · OTC:BIOLQ
Biolase — Sidoti & Company Fall 2018 Investor Conference
24 slides from Biolase's conference presentation, Sep 26, 2018
Slide 1: Advancing Dentistry
Exhibit 99.1 Advancing Dentistry Sidoti & Company Fall 2018 Investor Conference September 26, 2018 NASDAQ CM:BIOLExhibit 99.1 Advancing Dentistry Sidoti & Company Fall 2018 Investor Conference September 26, 2018 NASDAQ CM:BIOL
Slide 2: BIOLASE at a Glance – Global Leader in Dental Lasers
BIOLASE at a Glance – Global Leader in Dental Lasers ~37,600 318 ~200 Issued or Pending Employees Lasers Sold Globally Patents Worldwide % of 80 >50 3 4 FDA-Cleared Indications Share of Global All-tissue Lasers Sold for Waterlase® and Epic Dental Laser Globally are Market Waterlase % 97 ~30 Million
Slide 3: BIOLASE – Strengths
BIOLASE – Strengths • Brand value • Dental market leadership • Technology and new product leadership • Committed users • Expanding base of new customers • Large intellectual property portfolio • Strong management team and Board 3BIOLASE – Strengths • Brand value • Dental market leadership • Technolo
Slide 4: BIOLASE – The Continuing Story
BIOLASE – The Continuing Story • Late-stage turnaround • Significantly improved product reliability, support and education in past 3 years • Board enhanced with addition of extensive dental expertise • Southern CA Initiative for Model Market program • CEO transition – Todd A. Norbe, joined the Board
Slide 5: BIOLASE – The Continuing Story, 2018 Initiatives
BIOLASE – The Continuing Story, 2018 Initiatives Complete sales team transformation Establish community service relationships • In process – recent sales hires are • Partnered with Healthy Smiles for among our best performing Kids of Orange County and • Training includes “How does a TeamSmile (LA Ch
Slide 6: A Growing Full-spectrum Portfolio of Laser Systems and Procedural Consumables
A Growing Full-spectrum Portfolio of Laser Systems and Procedural Consumables Waterlase iPlus™ • World’s best selling All-Tissue dental laser- 80 FDA cleared indications • Replaces drill with substantial reduced need for anesthesia for teeth & bone • Replaces scalpel for minimally invasive, minimall
Slide 7: Investment Thesis
Investment Thesis Disrupting Dentistry with Exceptional Laser Technology and Products, World-class Education and Support: • Late-stage turnaround – focused on renewed revenue and profit growth • Strategic pivot to focus on high-value, prevalent and undertreated diseases • Industry-leading innovation
Slide 8: Model Market Initiative – Focus on Demonstrating Adoption in the Marketplace
Model Market Initiative – Focus on Demonstrating Adoption in the Marketplace • Started in late 2017, to test different sales and marketing tactics to increase general laser awareness, ultimately sales ‒ Focus resources in Los Angeles and Orange County • 10% of dentists in U.S., largest presence of D
Slide 9: Model Market – Early Results to Date
Model Market – Early Results to Date • 2Q18 all-tissue laser sales increased ~200% Y-O-Y ‒ >70% confidence pipeline for Model Market increased 8X Y-O-Y • Achieved with only 8% of “High Priority” targets contacted ‒ 70-80 contacts per week, ongoing • Media impressions have increased – Biolase Twitter
Slide 10: 2Q18 Overview
2Q18 Overview • Worldwide revenue $12.2 million compared to $12.6 million in 2Q17, which included large one-time buy of non-core imaging products • 2Q18 core dental laser and related product revenue up 1% Y-O-Y • Worldwide revenue up sequentially >21% from 1Q18 • In direct market >66% of all-tissue
Slide 11: Growth Opportunity in Bringing Europe “On Par” with U.S.
Growth Opportunity in Bringing Europe “On Par” with U.S. 68% of 2018 Revenue To-Date from Laser System Sales, 64% of Sales Made in U.S. Royalties 0% Services/Warranties International 13% United States 36% Laser Systems 64% 68% Consumables 13% Revenue by Revenue by Region Category Imaging Systems 6%
Slide 12: Market Opportunity – All-Tissue Lasers
Market Opportunity – All-Tissue Lasers 1 • 176,000 dentists in US & Canada • >1.4 Million dentists in 134 other countries – Rapid growth in emerging economies 2 – e.g. China, India and Indonesia • Current market penetration ‒ ~7.0% of dental practices in US ‒ ~1.4% worldwide • Each 1% increase in ma
Slide 13: BIOLASE Has Dominant Share in All-Tissue Laser Markets
BIOLASE Has Dominant Share in All-Tissue Laser Markets, Market Leadership in Soft-Tissue Lasers All Tissue Lasers Global Share Others Deka 7% 4% J.Morita 9% Types of Dental Lasers Sold - Lifetime Syneron Biolase 11% 52% All Tissue 13% Fotona 14% Soft Tissue 87% Soft Tissue Lasers Global Share Elexxi
Slide 14: A Significant Growth Opportunity
A Significant Growth Opportunity >60 Million People in U.S. Alone Have Gum Disease and Health Risk of Oral-systemic Connection Under-diagnosed, Under-treated, Under-managed 14A Significant Growth Opportunity >60 Million People in U.S. Alone Have Gum Disease and Health Risk of Oral-systemic Connectio
Slide 15: Dental Drills Vibrate & Create Heat, Heat = Pain
Dental Drills Vibrate & Create Heat, Heat = Pain … There is a better way! “My goal with Waterlase is to develop a generation of children where they can come into the dental office, and they don’t have any fear. I don’t give them any anesthetic and they can go back to school or out to play with no nu
Slide 16: What Patients Say About Waterlase
What Patients Say About Waterlase 16What Patients Say About Waterlase 16
Slide 17: Laser Dentistry Can Disrupt the Market
Laser Dentistry Can Disrupt the Market – 1 It Addresses the Challenges Faced by Today’s Dentists • According to ADA, CDC and Other Professional Organizations Challenges Include: ‒ Better patient reported outcomes ‒ Average pay decreasing over last 10 years ‒ Dentistry more competitive – the need to
Slide 18: Spreading The Word – New TV Commercial
Spreading The Word – New TV Commercial 18Spreading The Word – New TV Commercial 18
Slide 19: Delivering Better Patient Outcomes
Delivering Better Patient Outcomes Waterlase Laser Dentistry provides an entirely new patient experience with increased comfort and less of the anxiety and pain ordinary dentistry can cause Decreased Increased • Health• Anesthetic • Healing• Scars .. • Discomfort • Esthetics • Tooth preservation• Fe
Slide 20: Dental Lasers – Better Dentistry, Better Business
Dental Lasers – Better Dentistry, Better Business Procedure-based Laser Solutions Enable Professional and Practice Vitality Globally Increased Decreased • Positive outcomes• Complications • Patient excitement• Anxiety • Healing• Chair time • Competitiveness • Local market buzz • Cash flow 20Dental L
Slide 21: Positive Cash Flow – Investment in Patient Outcomes and Business Returns
Positive Cash Flow – Investment in Patient Outcomes and Business Returns Very Few Additional Procedures per Month, Can Upgrade Patient Experience & ROI WL Express Lease Cost: $840/Month New Procedures (of dozens available) & Representative Fee/Reimbursement Avg. (net of consumable cost) No./ Procedu
Slide 22: BIOLASE Stock Data: (NASDAQ CM:BIOL)
BIOLASE Stock Data: (NASDAQ CM:BIOL)* 52 Week Price Range $1.14 - $3.95 Recent Price (September 21, 2018) $2.17 Average Daily Volume (50 Days) 65,390 Common Shares Outstanding (August 6, 2018) 20,596,901 Market Capitalization (September 21, 2018) $44,695,275 *Adjusted for 1 for 5 reverse split of co
Slide 23: Safe Harbor Statement
Safe Harbor Statement Statements made in this presentation and during discussions with BIOLASE representative’s that refer to BIOLASE’s estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements its representatives make concerning BIOL
Slide 24: Questions and Answers
Questions and Answers 24Questions and Answers 24
Biolase — Sidoti & Company Fall 2018 Investor Conference on 6ix